Third, phosphorylation of iRhom2 is required for 14-3-3 binding in A549 cells (Fig. 5C), indicating that the phosphorylated iRhom2/14-3-3/ADAM17 activation pathway controls shedding of the ERBB ligands in these lung cancer cells. This evidence concerns the gene ADAM17 and lung cancer.